HomeCompareNBLD vs ABBV

NBLD vs ABBV: Dividend Comparison 2026

NBLD yields 189.57% · ABBV yields 3.06%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NBLD wins by $87.76M in total portfolio value
10 years
NBLD
NBLD
● Live price
189.57%
Share price
$1.06
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$87.86M
Annual income
$43,117,082.25
Full NBLD calculator →
ABBV
AbbVie Inc.
● Live price
3.06%
Share price
$217.44
Annual div
$6.65
5Y div CAGR
40.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$102.3K
Annual income
$24,771.77
Full ABBV calculator →

Portfolio growth — NBLD vs ABBV

📍 NBLD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNBLDABBV
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NBLD + ABBV cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NBLD pays
ABBV pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NBLD
Annual income on $10K today (after 15% tax)
$16,113.74/yr
After 10yr DRIP, annual income (after tax)
$36,649,519.91/yr
ABBV
Annual income on $10K today (after 15% tax)
$259.96/yr
After 10yr DRIP, annual income (after tax)
$21,056.00/yr
At 15% tax rate, NBLD beats the other by $36,628,463.91/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NBLD + ABBV for your $10,000?

NBLD: 50%ABBV: 50%
100% ABBV50/50100% NBLD
Portfolio after 10yr
$43.98M
Annual income
$21,570,927.01/yr
Blended yield
49.05%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ABBV right now

NBLD
No analyst data
ABBV
Analyst Ratings
27
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$256.15
+17.8% upside vs current
Range: $223.00 — $299.00
Altman Z
2.0
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NBLD buys
0
ABBV buys
0
No recent congressional trades found for NBLD or ABBV in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNBLDABBV
Forward yield189.57%3.06%
Annual dividend / share$2.00$6.65
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.6%
Portfolio after 10y$87.86M$102.3K
Annual income after 10y$43,117,082.25$24,771.77
Total dividends collected$82.55M$61.0K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: NBLD vs ABBV ($10,000, DRIP)

YearNBLD PortfolioNBLD Income/yrABBV PortfolioABBV Income/yrGap
1← crossover$29,657$18,957.35$11,550$430.00+$18.1KNBLD
2$84,278$52,544.35$13,472$627.96+$70.8KNBLD
3$229,725$139,547.71$15,906$926.08+$213.8KNBLD
4$601,301$355,495.58$19,071$1,382.55+$582.2KNBLD
5$1,513,022$869,629.94$23,302$2,095.81+$1.49MNBLD
6$3,663,984$2,045,050.10$29,150$3,237.93+$3.63MNBLD
7$8,548,836$4,628,373.75$37,536$5,121.41+$8.51MNBLD
8$19,239,740$10,092,484.76$50,079$8,338.38+$19.19MNBLD
9$41,814,396$21,227,874.37$69,753$14,065.80+$41.74MNBLD
10$87,858,486$43,117,082.25$102,337$24,771.77+$87.76MNBLD

NBLD vs ABBV: Complete Analysis 2026

NBLDStock

Nestbuilder.com Corp. designs and manufactures primary and backup hydrogen fuel cell (HFC) power generation systems for rapid electric vehicle (EV) charging, office parks, data centers, and retail facilities. The company provides mobile and transportable HFC-powered EV rapid charge systems; hydrogen transport and refueling vehicles; hydrogen storage modules; and greenhouse HFC grids. It also offers infrastructure solutions and systems. The company is based in Lindon, Utah.

Full NBLD Calculator →

ABBVHealthcare

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Full ABBV Calculator →
📬

Get this NBLD vs ABBV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NBLD vs SCHDNBLD vs JEPINBLD vs ONBLD vs KONBLD vs MAINNBLD vs JNJNBLD vs MRKNBLD vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.